Categories: Uncategorized

Children coming to Delhi hospitals with post-Covid symptoms like headaches, brain fogging, say doctors

Adults and children who have battled Covid are reporting to hospitals in Delhi with post-coronavirus symptoms such as gastrointestinal difficulties, headaches, brain fogging, and shortness of breath, according to doctors at private hospitals.

Aside from MISC (multisystem inflammatory syndrome in children) problems, experts are also seeing youngsters who had mild Covid come to them with delays.

Dr Rahul Nagpal, Director, Pediatrics, Fortis Hospital Vasant Kunj said, “Fortunately, children did not have very severe Covid. We got a handful of patients who had congenital heart disease, some kidney disorders, severe asthma or obesity who required hospitalization.”

“Post-Covid we are seeing multisystem inflammatory syndrome in children. It happens in 1 to 2% of cases, but that is also a huge number. With proper drugs and identification, it can be cured. Then there are lots of patients with diarrhoea, fatigue, body ache, digestive issues,” he said.

AddThis Website Tools
Medically Speaking Team

Recent Posts

India’s Immunisation Coverage Soars from 73% to 95% in Two Years

Immunisation plays a crucial role in protecting children from life-threatening diseases. In the past two…

10 hours ago

Mounjaro vs. Ozempic: Which Is Safer for Weight Loss?

In recent years, new diabetes and weight loss medications have sparked widespread interest, particularly among…

11 hours ago

Nutraceuticals in India: Rising Popularity and Future Potential

Nutraceuticals, a fusion of "nutrition" and "pharmaceuticals," have emerged as a significant force in the…

11 hours ago

Statins and Ezetimibe: A Life-Saving Cholesterol-Lowering Combination

Heart disease remains one of the leading causes of death worldwide. For years, statins have…

11 hours ago

SARS-CoV-2: Still Circulating but Weaker, Say Experts

Five years after the COVID-19 pandemic brought the world to a standstill, the SARS-CoV-2 virus…

12 hours ago

Mounjaro Launched in India: Price & Impact on Diabetes and Obesity

Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…

2 days ago